Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Raw Materials (2020 - 2022)

Historic Raw Materials for AVITA Medical (RCEL) over the last 3 years, with Q4 2022 value amounting to $1.1 million.

  • AVITA Medical's Raw Materials fell 744.68% to $1.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.1 million, marking a year-over-year decrease of 744.68%. This contributed to the annual value of $1.1 million for FY2022, which is N/A changed from last year.
  • As of Q4 2022, AVITA Medical's Raw Materials stood at $1.1 million, which was down 744.68% from $1.2 million recorded in Q4 2021.
  • In the past 5 years, AVITA Medical's Raw Materials registered a high of $1.2 million during Q4 2021, and its lowest value of $947000.0 during Q2 2020.
  • Moreover, its 3-year median value for Raw Materials was $1.1 million (2021), whereas its average is $1.1 million.
  • As far as peak fluctuations go, AVITA Medical's Raw Materials skyrocketed by 369.59% in 2021, and later crashed by 744.68% in 2022.
  • Over the past 3 years, AVITA Medical's Raw Materials (Quarter) stood at $947000.0 in 2020, then grew by 29.04% to $1.2 million in 2021, then decreased by 7.45% to $1.1 million in 2022.
  • Its Raw Materials stands at $1.1 million for Q4 2022, versus $1.2 million for Q4 2021 and $982000.0 for Q2 2021.